New study identifies behaviors influencing prescribing decisions for new medicines in neurodegenerative diseases

A new pan-European study has identified the key behavioral factors that influence whether health care professionals prescribe new, novel or nonroutine treatments for patients with neurodegenerative diseases.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup